{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:35:20Z","timestamp":1788849320488,"version":"build-2803163510"},"reference-count":31,"publisher":"China Science Publishing & Media Ltd.","issue":"4","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["No.2018A030313949"],"award-info":[{"award-number":["No.2018A030313949"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos. 81673067 and 82073440"],"award-info":[{"award-number":["Nos. 81673067 and 82073440"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2021,2,1]]},"DOI":"10.1093\/abbs\/gmab008","type":"journal-article","created":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T20:10:59Z","timestamp":1611691859000},"page":"438-445","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":19,"title":["mTOR pathway regulates the differentiation of peripheral blood Th2\/Treg cell subsets in patients with pemphigus vulgaris"],"prefix":"10.3724","volume":"53","author":[{"given":"Kuan","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangde","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meinian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2021,2,23]]},"reference":[{"key":"null","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/7151285","volume":"2017","author":"Timoteo RP","year":"2017","unstructured":"Timoteo RP, Da SM, Miguel CB, Silva DA, Catarino JD, Rodrigues JV, Sales-Campos H. Th1\/Th17-related cytokines and chemokines and their implications in the pathogenesis of pemphigus vulgaris. Mediat Inflamm, 2017, 2017:","journal-title":"Mediat Inflamm"},{"key":"null","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1080\/08820130902943097","volume":"38","author":"Satyam A","year":"2009","unstructured":"Satyam A, Khandpur S, Sharma VK, Sharma A. Involvement of TH1\/TH2 cytokines in the pathogenesis of autoimmune skin disease\u2014pemphigus vulgaris. Immunol Invest, 2009, 38: 498-509.","journal-title":"Immunol Invest"},{"key":"null","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.159.4.2010","volume":"159","author":"Ishii K","year":"1997","unstructured":"Ishii K, Amagai M, Hall RP, Hashimoto T, Takayanagi A, Gamou S, Shimizu N. Characterization of autoantibodies in pemphigus using antigen-specific enzyme-linked immunosorbent assays with baculovirus-expressed recombinant desmogleins. J Immunol, 1997, 159: 2010-2017.","journal-title":"J Immunol"},{"key":"null","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/jdv.15770","volume":"34","author":"Yang A","year":"2020","unstructured":"Yang A, Xuan R, Melbourne W, Tran K, Murrell DF. Validation of the BIOCHIP test for the diagnosis of bullous pemphigoid, pemphigus vulgaris and pemphigus foliaceus. J Eur Acad Dermatol, 2020, 34: 153-160.","journal-title":"J Eur Acad Dermatol"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01578","volume":"10","author":"De Guise S","year":"2019","unstructured":"De Guise S, Levin M, Jasperse L, Risatti G, Wells RS. T helper cell subsets and their functions in common bottlenose dolphins (tursiops truncatus). Front Immunol, 2019, 10:","journal-title":"Front Immunol"},{"key":"null","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","volume":"30","author":"Delgoffe GM","year":"2009","unstructured":"Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, Worley PF. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity, 2009, 30: 832-844.","journal-title":"Immunity"},{"key":"null","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nri3198","volume":"12","author":"Chi H","year":"2012","unstructured":"Chi H. Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol, 2012, 12: 325-338.","journal-title":"Nat Rev Immunol"},{"key":"null","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1177\/0961203318819131","volume":"28","author":"Wei S","year":"2018","unstructured":"Wei S, Xie S, Yang Z, Peng X, Gong L, Zhao K, Zeng K. Allogeneic adipose-derived stem cells suppress mTORC1 pathway in a murine model of systemic lupus erythematosus. Lupus, 2018, 28: 199-209.","journal-title":"Lupus"},{"key":"null","first-page":"927","volume":"9","author":"Kneisel A","year":"2011","unstructured":"Kneisel A, Hertl M. Autoimmune bullous skin diseases. Part 2: diagnosis and therapy. J Dtsch Dermatol Ges, 2011, 9: 927-947.","journal-title":"J Dtsch Dermatol Ges"},{"key":"null","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/bjd.14405","volume":"175","author":"Boulard C","year":"2016","unstructured":"Boulard C, Duvert LS, Picard-Dahan C, Kern JS, Zambruno G, Feliciani C, Marinovic B. Calculation of cut-off values based on the autoimmune bullous skin disorder intensity score (ABSIS) and pemphigus disease area index (PDAI) pemphigus scoring systems for defining moderate, significant and extensive types of pemphigus. Br J Dermatol, 2016, 175: 142-149.","journal-title":"Br J Dermatol"},{"key":"null","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1084\/jem.20060772","volume":"203","author":"Liu W","year":"2006","unstructured":"Liu W, Putnam AL, Xu-Yu Z, Szot GL, Lee MR, Zhu S, Gottlieb PA. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ Treg cells. J Exp Med, 2006, 203: 1701-1711.","journal-title":"J Exp Med"},{"key":"null","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1046\/j.1365-2133.1999.02612.x","volume":"140","author":"Scully C","year":"1999","unstructured":"Scully C, Paes DAO, Porter SR, Gilkes JJ. Pemphigus vulgaris: the manifestations and long-term management of 55 patients with oral lesions. Br J Dermatol, 1999, 140: 84-89.","journal-title":"Br J Dermatol"},{"key":"null","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.4049\/jimmunol.181.2.1526","volume":"181","author":"Takahashi H","year":"2008","unstructured":"Takahashi H, Amagai M, Nishikawa T, Fujii Y, Kawakami Y, Kuwana M. Novel system evaluating in vivo pathogenicity of desmoglein 3-reactive T cell clones using murine pemphigus vulgaris. J Immunol, 2008, 181: 1526-1535.","journal-title":"J Immunol"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2019.105912","volume":"77","author":"Feng M","year":"2019","unstructured":"Feng M, Guo H, Zhang C, Wang Y, Liang Z, Zhao X, Qin Y. Absolute reduction of regulatory T cells and regulatory effect of short-term and low-dose IL-2 in polymyositis or dermatomyositis. Int Immunopharmacol, 2019, 77:","journal-title":"Int Immunopharmacol"},{"key":"null","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.clim.2009.11.006","volume":"134","author":"Nagel A","year":"2010","unstructured":"Nagel A, Lang A, Engel D, Podstawa E, Hunzelmann N, de Pita O, Borradori L. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3. Clin Immunol, 2010, 134: 320-330.","journal-title":"Clin Immunol"},{"key":"null","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1365-2230.2005.01836.x","volume":"30","author":"Rizzo C","year":"2005","unstructured":"Rizzo C, Fotino M, Zhang Y, Chow S, Spizuoco A, Sinha AA. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease. Clin Exp Dermatol, 2005, 30: 535-540.","journal-title":"Clin Exp Dermatol"},{"key":"null","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.cyto.2015.09.017","volume":"77","author":"Tavakolpour S","year":"2016","unstructured":"Tavakolpour S, Tavakolpour V. Interleukin 4 inhibition as a potential therapeutic in pemphigus. Cytokine, 2016, 77: 189-195.","journal-title":"Cytokine"},{"key":"null","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s10875-011-9597-4","volume":"32","author":"Zhu H","year":"2012","unstructured":"Zhu H, Chen Y, Zhou Y, Wang Y, Zheng J, Pan M. Cognate Th2-B cell interaction is essential for the autoantibody production in pemphigus vulgaris. J Clin Immunol, 2012, 32: 114-123.","journal-title":"J Clin Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.4049\/jimmunol.145.11.3796","volume":"145","author":"Swain SL","year":"1990","unstructured":"Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol, 1990, 145: 3796-3806.","journal-title":"J Immunol"},{"key":"null","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/exd.12919","volume":"25","author":"Schmidt T","year":"2016","unstructured":"Schmidt T, Willenborg S, Hunig T, Deeg CA, Sonderstrup G, Hertl M, Eming R. Induction of T regulatory cells by the superagonistic anti-CD28 antibody D665 leads to decreased pathogenic IgG autoantibodies against desmoglein 3 in a HLA-transgenic mouse model of pemphigus vulgaris. Exp Dermatol, 2016, 25: 293-298.","journal-title":"Exp Dermatol"},{"key":"null","doi-asserted-by":"publisher","first-page":"8338","DOI":"10.4049\/jimmunol.177.12.8338","volume":"177","author":"Battaglia M","year":"2006","unstructured":"Battaglia M, Stabilini A, Migliavacca B, Horejs-Hoeck J, Kaupper T, Roncarolo MG. Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol, 2006, 177: 8338-8347.","journal-title":"J Immunol"},{"key":"null","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.immuni.2014.06.006","volume":"41","author":"Tindemans I","year":"2014","unstructured":"Tindemans I, Serafini N, Di Santo JP, Hendriks RW. GATA-3 function in innate and adaptive immunity. Immunity, 2014, 41: 191-206.","journal-title":"Immunity"},{"key":"null","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.4049\/jimmunol.176.5.3215","volume":"176","author":"Veldman C","year":"2006","unstructured":"Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G. Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol, 2006, 176: 3215-3222.","journal-title":"J Immunol"},{"key":"null","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","volume":"12","author":"Perl A","year":"2016","unstructured":"Perl A. Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nat Rev Rheumatol, 2016, 12: 169-182.","journal-title":"Nat Rev Rheumatol"},{"key":"null","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.cellsig.2007.12.004","volume":"20","author":"Ma K","year":"2008","unstructured":"Ma K, Cheung SM, Marshall AJ, Duronio V. PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB\/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity. Cell Signal, 2008, 20: 684-694.","journal-title":"Cell Signal"},{"key":"null","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/imr.12796","volume":"291","author":"Myers DR","year":"2019","unstructured":"Myers DR, Wheeler B, Roose JP. mTOR and other effector kinase signals that impact T cell function and activity. Immunol Rev, 2019, 291: 134-153.","journal-title":"Immunol Rev"},{"key":"null","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04826-y","volume":"7","author":"Zhang Y","year":"2017","unstructured":"Zhang Y, Jing Y, Qiao J, Luan B, Wang X, Wang L, Song Z. Activation of the mTOR signaling pathway is required for asthma onset. Sci Rep-UK, 2017, 7:","journal-title":"Sci Rep-UK"},{"key":"null","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","volume":"111","author":"Zeiser R","year":"2008","unstructured":"Zeiser R, Leveson-Gower DB, Zambricki EA, Kambham N, Beilhack A, Loh J, Hou JZ. Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells. Blood, 2008, 111: 453-462.","journal-title":"Blood"},{"key":"null","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.celrep.2012.02.007","volume":"1","author":"Kurebayashi Y","year":"2012","unstructured":"Kurebayashi Y, Nagai S, Ikejiri A, Ohtani M, Ichiyama K, Baba Y, Yamada T. PI3K-Akt-mTORC1-S6K1\/2 axis controls Th17 differentiation by regulating Gfi1 expression and nuclear translocation of RORgamma. Cell Rep, 2012, 1: 360-373.","journal-title":"Cell Rep"},{"key":"null","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.4049\/jimmunol.0902544","volume":"185","author":"Cook KD","year":"2010","unstructured":"Cook KD, Miller J. TCR-dependent translational control of GATA-3 enhances Th2 differentiation. J Immunol, 2010, 185: 3209-3216.","journal-title":"J Immunol"},{"key":"null","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1172\/JCI73411","volume":"124","author":"Koga T","year":"2014","unstructured":"Koga T, Hedrich CM, Mizui M, Yoshida N, Otomo K, Lieberman LA, Rauen T. CaMK4-dependent activation of AKT\/mTOR and CREM-\u03b1 underlies autoimmunity-associated Th17 imbalance. J Clin Invest, 2014, 124: 2234-2245.","journal-title":"J Clin Invest"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/3D26147D75444484BED0BF1F516FD09A","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmab008","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/abbs\/article-pdf\/53\/4\/438\/36740638\/gmab008.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/engine.scichina.com\/doi\/pdf\/3D26147D75444484BED0BF1F516FD09A","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T06:42:03Z","timestamp":1697697723000},"score":1,"resource":{"primary":{"URL":"http:\/\/engine.scichina.com\/doi\/10.1093\/abbs\/gmab008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,1]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,2,23]]},"published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/abbs\/gmab008","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,1]]}}}